spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience

Oxford Genetics

They will allow Twist Bioscience to clone synthesized DNA for its diverse customer base

November 16, 2017, Oxford, England and San Francisco, Calif. – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, announced today a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast technology platform to provide a broad range of application-specific expression vectors which Twist Bioscience will use to clone synthesized DNA for its diverse customer base.

Dr Ryan Cawood, CEO of Oxford Genetics said, “This license agreement with Twist Bioscience serves as further recognition of our approach to developing the best optimised expression vectors. By utilising our SnapFast™ platform, Twist Bioscience is giving its customers access to the latest vector designs for the most demanding applications and providing them with better value, a streamlined workflow and maximum flexibility in order to utilise their custom DNA constructs to their best effect.”

Oxford Genetics specialises in the design of application specific vectors, which is a culmination of access to cutting edge bioinformatics, generation of extensive biological data, and continual refinement to ensure customer success. The vectors also grant access to the wider SnapFast™ ecosystem which allows Twist Bioscience to switch between all of Oxford Genetics’ vectors, making future changes and additions simple and efficient.

Emily M. Leproust PhD, CEO of Twist Bioscience, commented: “By complementing our ability to provide high throughput synthetic genes with a wide range of customized vectors from Oxford Genetics, we accelerate our customers' workflow, allowing them to solve more complex problems while saving both time and resources. Importantly, it enables us to reach the large group of customers who order smaller quantities of genes in standard vectors. We remain committed to optimizing our product line to enable our customers to succeed more quickly.”

Oxford Genetics Media Contact
Kate Hindhaugh
ramarketing
+44 (0) 7702 433450
kate@ramarketingpr.com

Twist Bioscience Corporation Contacts

Investors
Argot Partners
Maeve Conneighton
212-600-1902
maeve@argotpartners.com

Media Contact
Angela Bitting
925-202-6211
media@twistbioscience.com

About Oxford Genetics
Oxford Genetics, headquartered in Oxford, UK, is a leading synthetic biology company dedicated to the creation of biology-based technologies to aid in the discovery and development of biologics, cell and gene therapies. Founded in 2011, the company has experience in DNA design for the optimisation of protein expression, improved viral delivery systems and cell line engineering.
 
About Twist Bioscience Corporation
At Twist Bioscience Corporation, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts. Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Sign up to follow our Twitter feed @TwistBioscience.
phone +44 (0) 1865 309 664
web www.oxfordgenetics.com
email Oxford Genetics Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, Oxfordshire, OX5 1PF, United Kingdom
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Saudia Cargo launches state-of-the-art pharmaceutical cold storage facility at KAIA

MAY 2018 – Saudia Cargo has recently inaugurated one of the Region’s newest and most modern cold storage facilities of pharmaceuticals and medicines at King Abdulaziz International Airport (KAIA) to meet the surged demand on highly-sensitive and temperature-controlled shipments.
More info >>


White Papers

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

PCI Pharma Services

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >>

Industry Events

PPMA SHOW 2018

25-27 September 2018, NEC, Birmingham, UK

The UK’s leading production line event is celebrating its 30th Anniversary. Taking place at the NEC, Birmingham from 25-27 September 2018, the exhibition showcases the latest processing and packaging machinery. Attended by thousands of manufacturers of food, pharmaceuticals and FMCG as well as contract packers and more.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement